| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/30/2006 | US7052896 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 05/30/2006 | US7052895 nucleotide sequences that code amino acid sequences having hydrolase enzyme activity, used for medical diagnosis, for prophylaxis of diseases and drug screening; bioassay |
| 05/30/2006 | US7052892 For preventing, ameliorating, disorders or diseases including cancer, peripheral and central nervous system disorders, genitourinary disorders, cardiovascular disorders, and Chronic obstructive pulmonary (or airways) disease (COPD) |
| 05/30/2006 | US7052890 Transglutaminase gene products |
| 05/30/2006 | US7052889 Mammalian SUV39H2 proteins and isolated DNA molecules encoding them |
| 05/30/2006 | US7052887 Method for immobilization of (an) affinity reagent(s) on a hydrophobic solid phase |
| 05/30/2006 | US7052866 Method for evaluating the efficacy of an antifungal agent |
| 05/30/2006 | US7052864 Using optical indicator |
| 05/30/2006 | US7052863 Chromogenic substrate for use in monitoring and detecting preferential enzymatic activities |
| 05/30/2006 | US7052862 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 05/30/2006 | US7052861 Graphitic nanotubes in luminescence assays |
| 05/30/2006 | US7052860 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 05/30/2006 | US7052859 MUCIN 4 expression as a marker for pancreatic cancer |
| 05/30/2006 | US7052858 Novel Cryptosporidium parvum protein disulfide isomerase polypeptide, and nucleic acids that encode this polypeptide. The invention also provides methods, reagents, and kits that are useful for diagnosing infection by Cryptosporidium |
| 05/30/2006 | US7052857 Compounds that activate the olfactory CNG channel will enhance smell and can be used to make foods more palatable for individuals with attenuated olfactory function |
| 05/30/2006 | US7052856 Contacting a cell containing a NELL-1 gene with a test agent; and detecting a change in the expression level of Nell-1 gene as compared to the expression of the NELL-1 gene in a cell that is not contacted with test agent |
| 05/30/2006 | US7052855 Using apolipoprotein specific immunoglobulin to diagnosis and treat arteriosclerosis, hyperlipidemia and cardiovascular disorders |
| 05/30/2006 | US7052854 Application of nanotechnology and sensor technologies for ex-vivo diagnostics |
| 05/30/2006 | US7052853 Depression gene |
| 05/30/2006 | US7052852 CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker in alzheimer's disease |
| 05/30/2006 | US7052851 Crystal structure of cysteine protease |
| 05/30/2006 | US7052850 Isolated human EDG-4 receptor |
| 05/30/2006 | US7052849 Antibody for use in the diagnosis of diabetic disorders |
| 05/30/2006 | US7052847 solid phase synthesis using a mixture of nucleotides and nucleotide analogs, and a supported target DNA and DNA polymerase; template directed extension of a primer; spectrum analysis |
| 05/30/2006 | US7052843 Transcription-based assay for identification of post-translational modification and its application in proteomics |
| 05/30/2006 | US7052842 Method for highly sensitive hybridization of nucleic acids, and method for gene analysis using the same |
| 05/30/2006 | US7052837 Nucleotide sequences for use in the detection of histoplasma infections |
| 05/30/2006 | US7052835 Method of screening a gene |
| 05/30/2006 | US7052832 Determining sensitivity of a cell to reovirus infection; obtain cells, monitor ras protein signaling, consistent signaling indicates sensitivity to reovirus infection |
| 05/30/2006 | US7052831 Apparatus for use in the detection of influenza virus |
| 05/30/2006 | US7052703 T-cell receptorγ alternate reading frame protein, (TARP) and uses thereof |
| 05/30/2006 | US7052698 Surface proteins of Leptospira |
| 05/30/2006 | US7052693 Anti-human VEGF receptor FLT-1 monoclonal antibody |
| 05/30/2006 | US7052675 binding antibody to substrate; neutralization of infection prions; in vivo diagnosis testing |
| 05/30/2006 | US7052674 Prokineticin polypeptides, related compositions and methods |
| 05/30/2006 | US7052666 Annealing; oxidative etching |
| 05/30/2006 | US7052652 Analyte concentration detection devices and methods |
| 05/30/2006 | US7052570 Beads alignment structure, production method thereof, and bead alignment method for capillary beads array |
| 05/30/2006 | US7052514 Methods and reagents for tissue engineering of cartilage in vitro |
| 05/30/2006 | US7052468 Method and apparatus for detecting environmental smoke exposure |
| 05/30/2006 | US7051773 Liquid filling method, liquid filling apparatus, and discharge apparatus |
| 05/30/2006 | US7051606 Dosage form holder device and methods for immersion testing |
| 05/30/2006 | US7051581 High throughput rheological testing of materials |
| 05/30/2006 | US7051573 Gas sensor chamber and odor detection method |
| 05/30/2006 | US7051572 Process for determining the odor-inhibiting properties of textile auxiliaries |
| 05/30/2006 | CA2255201C Polyphasic flowmeter device and use |
| 05/30/2006 | CA2251924C Fluorescent chelates as visual tissue specific imaging agents |
| 05/29/2006 | CA2526684A1 Therapeutic peptides and method |
| 05/26/2006 | WO2006055925A2 Microarrays for analyte detection |
| 05/26/2006 | WO2006055883A2 Subnanomolar precipitator of thiophilic metals |
| 05/26/2006 | WO2006055880A2 Diagnostic pkm2 methods and compositions |
| 05/26/2006 | WO2006055852A1 Methods of developing a stem cell line |
| 05/26/2006 | WO2006055806A2 Diagnostic, prognostic, and therapeutic factor smac/diablo in human cancer |
| 05/26/2006 | WO2006055761A1 Methods of determining human egg competency |
| 05/26/2006 | WO2006055739A2 Stationary phase antibody arrays for trace protein analysis |
| 05/26/2006 | WO2006055680A2 Method for determining three-dimensional protein structure from primary protein sequence |
| 05/26/2006 | WO2006055527A2 Method for optimizing thiopurine efficacy and toxicity using mass spectrometry |
| 05/26/2006 | WO2006055502A1 Method of analyzing basestocks for low temperature properties |
| 05/26/2006 | WO2006055499A1 Method of analyzing basestocks for low temperature properties |
| 05/26/2006 | WO2006055488A2 Marker for fenestrae |
| 05/26/2006 | WO2006055360A1 Methods and systems for positioning microspheres for imaging |
| 05/26/2006 | WO2006055167A1 Regulation of f1-atpase beta subunit cellular location |
| 05/26/2006 | WO2006055040A2 Identification of proteins in a genome |
| 05/26/2006 | WO2006054991A1 Magnetic enrichment of circulating cells, fragments and debris for enabling hts proteomics and genomics in disease detection |
| 05/26/2006 | WO2006054961A2 Novel composition and methods for the treatment of immune related diseases |
| 05/26/2006 | WO2006054931A1 The use and identification of antagonists of protease-activated receptor 3 (par3) in the treatment of asthma |
| 05/26/2006 | WO2006054862A1 Method for measuring heptoglobin level in blood serum and kit therefor |
| 05/26/2006 | WO2006054806A1 Crohn’s disease-associated autoantigen |
| 05/26/2006 | WO2006054798A1 Reagent containing oxygen isotope-labeled hemoglobin for examining vital tissue and method of producing the same |
| 05/26/2006 | WO2006054770A1 Novel map kinase kinase kinase (mapkkk) |
| 05/26/2006 | WO2006054755A1 Method of screening candidate for drug |
| 05/26/2006 | WO2006054740A1 Nucleic acid fragments for detecting nucleic acid and method of detecting nucleic acid |
| 05/26/2006 | WO2006054690A1 Method of detecting gene polymorphism, method of diagnosing, apparatus therefor and test reagent kit |
| 05/26/2006 | WO2006054683A1 Method of detecting antibody with the use of cell-free protein synthesis system and method of screening specific protein |
| 05/26/2006 | WO2006054652A1 Amide compound |
| 05/26/2006 | WO2006054641A1 Gpr7-selective ligand and use thereof |
| 05/26/2006 | WO2006054537A1 Method of screening, or evaluating, therapeutic agent for urinary lithiasis |
| 05/26/2006 | WO2006054519A1 Standard item for fractional determination of component of lipoprotein |
| 05/26/2006 | WO2006054449A1 Biomolecule interaction test instrument, biomolecule interaction test method, biomolecule dissolution temperature measuring method, nucleic acid sequence detecting method biomolecule interacting method, and biomolecule mobilizing method |
| 05/26/2006 | WO2006054448A1 Human serum for cell culture |
| 05/26/2006 | WO2006054426A1 Hydrophobic fluorescent probe of high-fluorescent quantum efficiency type, and method of detecting biopolymer and method of detecting interaction between biopolymers by using the same |
| 05/26/2006 | WO2006054415A1 In vitro evaluation method for activity of modifying immune response |
| 05/26/2006 | WO2006054326A2 Animal model for studying substances with cardiotherapeutic and anti-hypertensive activity |
| 05/26/2006 | WO2006054076A1 Methods for monitoring hydrate inhibition, and early warning system for hydrate formation |
| 05/26/2006 | WO2006054068A2 Assay method |
| 05/26/2006 | WO2006053903A2 Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors |
| 05/26/2006 | WO2006053865A1 Miniaturised autonomous diagnostic device |
| 05/26/2006 | WO2006053680A1 Ex vivo cancer diagnostic method |
| 05/26/2006 | WO2006053649A1 Method for the detection of cancer |
| 05/26/2006 | WO2006053592A1 Use of c3a and derivatives thereof as a biomarker for colorectal ademona and/or carcinoma; diagnosis method and test system using the same |
| 05/26/2006 | WO2006053568A1 Tnf antagonists |
| 05/26/2006 | WO2006053463A1 A testing method of nucleic acid binding protein based on biochip |
| 05/26/2006 | WO2006053443A1 Detection of intact recombinant viruses |
| 05/26/2006 | WO2006053442A1 Calml3 a specific and sensitive target for lung cancer diagnosis, prognosis and/or theranosis |
| 05/26/2006 | WO2006053439A1 Hcv f protein and uses thereof |
| 05/26/2006 | WO2006042035A3 Method of monitoring anti-tumor activity of an hdac inhibitor |
| 05/26/2006 | WO2006038904A3 Method and compositions for treating diseases targeting e-cadherin |
| 05/26/2006 | WO2006033843A3 Lanthanide-based substrates and methods for determining clostridial toxin activity |
| 05/26/2006 | WO2006031963A3 Metabolite markers for weight management |
| 05/26/2006 | WO2006030420A3 Continuous monitoring system |